Back to Point72 Asset Management, L.P. Point72 Asset Management, L.P.

GILD

Showing 7 of 26 quarters

Position history for Point72 Asset Management, L.P.Point72 Asset Management, L.P.'s holdings in Gilead Sciences, Inc.

Yes. Point72 Asset Management holds 1,437,685 shares of GILD (Gilead Sciences), worth $181.6M, as of its Q2 2026 13F filing. It increased the position from 8,808 shares in Q1 2026. Point72 Asset Management has held GILD since Q1 2026, across 2 quarterly 13F filings. GILD is 0.2% of Point72 Asset Management's reported 13F portfolio.

Current Value

$181.6M

Current Shares

1.4M

Total Value Change

-$11.6M

Total Shares Change

-867,585

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.4M
+162x
$181.6M0.2%$125.63
59
2026-Q1
New
8,808
-
$1.2M0.0%$137.68
35
2025-Q3
Exited
0
-100.0%
$00.0%$108.32
0
2025-Q2
Decreased
164,728
-67.8%
$18.3M0.0%$107.45
0
2025-Q1
Decreased
510,736
-40.4%
$57.2M0.1%$107.83
0
2024-Q4
Decreased
856,657
-62.8%
$79.1M0.2%$88.27
0
2024-Q3
Increased
2.3M
+350.1%
$193.3M0.5%$79.45
59

Other major holders of GILD: BlackRock, Inc., Vanguard Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used